Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 140

Results For "Officer"

2010 News Found

BioIVT promotes Dr. Richard Haigh to CEO
People | August 02, 2022

BioIVT promotes Dr. Richard Haigh to CEO


Ayush Minister Sonowal inaugurates Ayush Building Complex in Navi Mumbai
Policy | August 01, 2022

Ayush Minister Sonowal inaugurates Ayush Building Complex in Navi Mumbai

Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively


Cariflex breaks ground on world's largest polyisoprene latex plant in Singapore
News | July 29, 2022

Cariflex breaks ground on world's largest polyisoprene latex plant in Singapore

Driven by a strong commitment to better serve its global customers in medical and consumer products, this investment represents the largest capacity expansion in Cariflex’s existing accomplishments


India has achieved replacement level fertility: Minister Pawar
Policy | July 28, 2022

India has achieved replacement level fertility: Minister Pawar

Pawar also unveiled the India Family Planning 2030 vision document and launched the Medical Eligibility Criteria (MEC) Wheel Application, E-Module of Family Planning Logistics Management System (FPLMIS) and Digital Archive on Family Planning under the category of Digital Intervention.


Syngene reports revenue from operations up 8% in Q1 FY 23
News | July 21, 2022

Syngene reports revenue from operations up 8% in Q1 FY 23

Company raises the annual revenue guidance from mid-teens to high teens


Essential Pharma progress in its ESG performance
Sustainability | July 20, 2022

Essential Pharma progress in its ESG performance

The company now exceeds the sector benchmark for its overall ESG rating and for all three measures


Brii Bio inks partnership with China Resources Pharmaceutical to advance the commercialization of Long-acting COVID-19 neutralizing antibody therapy
Drug Approval | July 20, 2022

Brii Bio inks partnership with China Resources Pharmaceutical to advance the commercialization of Long-acting COVID-19 neutralizing antibody therapy

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China